中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2013年
23期
1450-1454
,共5页
丛进春%陈春生%冯勇%马明星%夏志秀%刘鼎盛
叢進春%陳春生%馮勇%馬明星%夏誌秀%劉鼎盛
총진춘%진춘생%풍용%마명성%하지수%류정성
直肠癌%新辅助放化疗%经内外括约肌间切除术%肛门功能
直腸癌%新輔助放化療%經內外括約肌間切除術%肛門功能
직장암%신보조방화료%경내외괄약기간절제술%항문공능
rectal cancer%neoadjuvant chemoradiotherapy%intersphincteric resection%anal sphincter function
目的:进展期的低位直肠癌行新辅助治疗可明显降低局部复发,但是也可能会带来肛门功能的受损。本研究探讨新辅助治疗对经内外括约肌间切除术(intersphincteric resection,ISR)术后肛门功能的影响程度。方法:选取2005年9月至2011年3月中国医科大学附属盛京医院103例行ISR手术的低位直肠癌患者,按照是否接受术前新辅助治疗分为CRT组(术前放化疗组)和对照组,通过向量测压、Saito功能问卷和Wexner评分来比较两组的肛门功能。结果:CRT组的术前静息向量容积和收缩向量容积要明显低于对照组,术后两组的测压结果均显著下降,CRT组的所有指标均低于对照组(P<0.05)。在6、12个月Saito功能问卷结果除排便困难两组间没有差异外,其余CRT组结果均明显不如对照组;在术后24个月,排便频率、排便截断、气便分辨能力以及限制饮食4项CRT组仍不及对照组(P<0.05)。到术后24个月,两组Wexner评分均有下降趋势,CRT组高于对照组(P<0.05)。结论:对于需行ISR手术的低位直肠癌,新辅助治疗会明显的影响术后的肛门功能,而且这种影响要至少会持续2年时间。
目的:進展期的低位直腸癌行新輔助治療可明顯降低跼部複髮,但是也可能會帶來肛門功能的受損。本研究探討新輔助治療對經內外括約肌間切除術(intersphincteric resection,ISR)術後肛門功能的影響程度。方法:選取2005年9月至2011年3月中國醫科大學附屬盛京醫院103例行ISR手術的低位直腸癌患者,按照是否接受術前新輔助治療分為CRT組(術前放化療組)和對照組,通過嚮量測壓、Saito功能問捲和Wexner評分來比較兩組的肛門功能。結果:CRT組的術前靜息嚮量容積和收縮嚮量容積要明顯低于對照組,術後兩組的測壓結果均顯著下降,CRT組的所有指標均低于對照組(P<0.05)。在6、12箇月Saito功能問捲結果除排便睏難兩組間沒有差異外,其餘CRT組結果均明顯不如對照組;在術後24箇月,排便頻率、排便截斷、氣便分辨能力以及限製飲食4項CRT組仍不及對照組(P<0.05)。到術後24箇月,兩組Wexner評分均有下降趨勢,CRT組高于對照組(P<0.05)。結論:對于需行ISR手術的低位直腸癌,新輔助治療會明顯的影響術後的肛門功能,而且這種影響要至少會持續2年時間。
목적:진전기적저위직장암행신보조치료가명현강저국부복발,단시야가능회대래항문공능적수손。본연구탐토신보조치료대경내외괄약기간절제술(intersphincteric resection,ISR)술후항문공능적영향정도。방법:선취2005년9월지2011년3월중국의과대학부속성경의원103례행ISR수술적저위직장암환자,안조시부접수술전신보조치료분위CRT조(술전방화료조)화대조조,통과향량측압、Saito공능문권화Wexner평분래비교량조적항문공능。결과:CRT조적술전정식향량용적화수축향량용적요명현저우대조조,술후량조적측압결과균현저하강,CRT조적소유지표균저우대조조(P<0.05)。재6、12개월Saito공능문권결과제배편곤난량조간몰유차이외,기여CRT조결과균명현불여대조조;재술후24개월,배편빈솔、배편절단、기편분변능력이급한제음식4항CRT조잉불급대조조(P<0.05)。도술후24개월,량조Wexner평분균유하강추세,CRT조고우대조조(P<0.05)。결론:대우수행ISR수술적저위직장암,신보조치료회명현적영향술후적항문공능,이차저충영향요지소회지속2년시간。
Objective:To evaluate the effects of neoadjuvant chemoradiotherapy on anal function after intersphincteric resection (ISR) with low rectal cancer. Methods:A total of 103 patients were classified into the chemoradiotherapy (CRT) group and control group according to whether they received neoadjuvant chemoradiotherapy. Anal function was assessed using vectorial manometry, Saito function questionnaires, and Wexner incontinence scores. Results:The resting vector volume and squeezing vector volume of the CRT group were significantly lower than those of the control group prior to the operation. Both groups showed decreasing manometric re-sults after ISR. However, all indices of the CRT group were significantly lower than those of the control group (P<0.05). At 6 and 12 months after operation, the Saito questionnaire results reveal poor function for the CRT group compared with the control group, except for dyschesia. After 24 months, the stool frequency, ability to distinguish between feces and flatus, fragmentation, and alimentary re-striction remained poor for the CRT group (P<0.05). Although both groups showed decreasing Wexner scores with time, the score of the CRT group remained significantly higher than that of the control up to 24 months after operation. Conclusion:Neoadjuvant chemo-radiotherapy significantly affects the anal sphincter function for intersphincteric resection with low rectal cancer. This effect continues for at least 2 years after operation.